Drug discovery for kinetoplastid diseases: future directions

by Rao S, Barrett M, Dranoff G, Farady C, Gimpelewicz C, Hailu A, Jones C, Kelly J, Lazdins-Helds J, Maeser P, Mengel J, Mottram J, Mowbray C, Sacks D, Scott P, Späth G, Tarleton RL, Spector J, Diagana T.

American Chemical Society Infectious Diseases, December 2018

ASTMH 2018

67th Annual Meeting

28 October – 1 November 2018
New Orleans, USA

  • Nathalie Strub-Wourgaft, NTD Director – presentation on fexinidazole in a symposium on sleeping sickness elimination
  • Colin Forsyth, Chagas Epidemiologist, Sergio Sosa Estani, Head of Chagas Clinical Programme, Eric Chatelain, Head of Drug Discovery Programme – symposium on screening and diagnosis of Chagas disease
  • Poster and oral presentations on sleeping sickness, visceral leishmaniasis, Chagas, onchocerciasis, and mycetoma

COR-NTD Annual Meeting

26-27 October 2018
New Orleans, USA

  • Sergio Sosa-Estani, Head of Chagas Clinical Program, and Andrea Marchiol, Chagas Access Project Manager – session on control and care of Chagas disease in health networks
  • Suman Rijal, Head Regional Office, DNDi India – presentation on VL/HIV co-infections and PKDL

DNDi announces new Director of Neglected Tropical Diseases

Former DNDi Medical Director Dr Nathalie Strub-Wourgaft takes over leadership of NTD programme

DNDi is pleased to announce the appointment of Dr Nathalie Strub-Wourgaft as the new Director of Neglected Tropical Diseases. She will assume her new role as NTD Director and member of DNDi’s Executive Team as of 1 July 2018.

MedTrop 2018

Congress of the Brazilian Society of Tropical Medicine

2-5 September 2018 
Recife, Brazil
Posters on advances and challenges for Chagas disease and an access project in Colombia
DNDi participating in several round tables on Chagas disease and cutaneous leishmaniasis and the satellite forum FSBEIN